Veranex Archives - Medical Design Sourcing

Veranex names Tom Daulton as CEO

Veranex CEO Tom Daulton (left) and COO David Dockhorn (right) [Image courtesy of Veranex]Veranex today announced it appointed Tom Dalton as CEO as David Dockhorn steps down to become chief operating officer.

Dalton has more than 30 years of healthcare leadership experience. He most recently was chair and CEO of National Dentex Labs. He also has leadership experience from Baxter, Allegiance Healthcare and Cardinal Health, and was the founder and CEO of Devicor Medical Products.

“I am thrilled to join this exceptional team and continue the progress David has already championed,” Daulton said. “As an end-to-end MedTech service provider, Veranex is clearly poised for an exciting future. My background — including experience building two large global healthcare businesses — has afforded me a solid understanding of how to knit a variety of cultures together into a powerful, unified business. I look forward to working closely with the team to build on Veranex’s role as a …

Veranex acquires medtech design firm Worrell

Veranex today announced that it has acquired medtech design firm Worrell for an undisclosed amount.

Raleigh, N.C.-based Veranex delivers strategic, operations and financial benefits to medical device companies and engineers that are developing breakthrough technologies, according to the company. The acquisition of Worrell will expand its offerings and geographic reach.

“The addition of Worrell strengthens Veranex’s offerings as the leading global provider in the medical device and biotech space. By enhancing our human-centered design capabilities with a focus on Phase 0 strategy, design conceptualization, and human factors services, we complement our existing ISO-certified Phase 1-4 engineering and pilot-scale manufacturing capabilities,” Veranex executive chairperson Patrick Donnelly said in a news release. “We’re thrilled to welcome the employees of Worrell to Veranex.”

Worrell’s president Kai Worrell will join Veranex as president of its p…

Adapting an existing laparoscopic or advanced energy device for a robotic platform

By Len Faria

Mechanical Engineering Manager, Veranex

Robotic assisted surgery (RAS) has seen impressive and sustained growth for the past decade with little sign of slowing down. New surgical modalities, differentiated visualization and navigation solutions along with increased connectivity continue to drive market adoption and utilization.

As the market matures, access to a broad catalogue of surgical tools will be one of the differentiating factors when hospital buyers evaluate the purchase of a new platform. We have seen first movers innovate and build a strong, ground-up offering while more established players leverage and adapt their existing robotic solution portfolios to take advantage of growth opportunities. Partnerships between platforms and laparoscopic and minimally invasive device manufacturers will bring new offerings to the table.

Key Considerations When Developing or Adapting Existing Tool Sets for Robotic Applicat…

Veranex acquires Experien Group

Veranex announced today that it acquired Experien Group, a provider of regulatory, quality and clinical consulting services for medtech companies.

Raleigh, N.C.-based Veranex, which was created as a combination of companies after Summit Partners acquired Ximedica, Quartesian and Boston Healthcare Associates in June, offers integrated product development strategies and services to medtech companies.

Get the full story at our sister site, Medical Design & Outsourcing.

Veranex acquires Experien Group

Veranex announced today that it acquired Experien Group, a provider of regulatory, quality and clinical consulting services for medtech companies.

Raleigh, N.C.-based Veranex, which was created as a combination of companies after Summit Partners acquired Ximedica, Quartesian and Boston Healthcare Associates in June, offers integrated product development strategies and services to medtech companies.

According to a news release, Veranex’s west coast operations will offer a unique, client-responsive consulting model designed to adjust to meet client program requirements as a result of the acquisition.

“We are excited to welcome Experien Group to Veranex,” Veranex CEO David Dockhorn said in the release. “With this acquisition, Veranex adds the premier provider of regulatory, quality, and clinical consulting services to medtech companies. Veranex’s clients will benefit from Experien’s long-standing FDA engagement, well-established global regulatory guid…

Ximedica, Quartesian, Boston Healthcare Associates combine into Veranex

Private equity firm Summit Partners has acquired Ximedica, Quartesian and Boston Healthcare Associates — rolling them into a new medtech service company called Veranex.

In its inaugural news release on June 16, the new Raleigh, N.C.- based company touted itself as the first concept-to-commercialization global service provider — with capabilities including design and engineering, regulatory, clinical, and market access.

Get the full story on our sister site Medical Design & Outsourcing.

Ximedica, Quartesian, Boston Healthcare Associates combine into Veranex

Private equity firm Summit Partners has acquired Ximedica, Quartesian and Boston Healthcare Associates — rolling them into a new medtech service company called Veranex.

In its inaugural news release on June 16, the new Raleigh, N.C.- based company touted itself as the first concept-to-commercialization global service provider — with capabilities including design and engineering, regulatory, clinical, and market access.

The financial terms of the deal were not disclosed. Veranex’s leadership includes CEO David Dockhorn, whose 32 years of life sciences experience includes co-founding a full-service contract research organization sold to Carlyle in 1997 and integrated into PRA Health Sciences. In addition, executive chair Pat Donnelly has more than 25 years as a pharma services founder and executive, serving as CEO of Advarra until last year.

“We are thrilled to partner with Pat Donnelly, David Dockhorn, and the rest of the Veranex management team to …